Novartis Eye Care Unit Buys PowerVision for $285M
Novartis AG said on Monday that its eye care division has agreed to buy privately held medical device development company PowerVision for $285 million, as the company looks to expand its...To view the full article, register now.
Already a subscriber? Click here to view full article